Abnormal tau phosphorylation has been identified as a key pathophysiological mechanism of neurodegenerative diseases, including Alzheimer’s disease (AD), frontotemporal dementia, and progressive supranuclear palsy (Noble et al., 2013). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.